Clinuvel Pharmaceuticals Ltd
ASX:CUV

Watchlist Manager
Clinuvel Pharmaceuticals Ltd Logo
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Watchlist
Price: 13.04 AUD -0.91% Market Closed
Market Cap: 652.8m AUD
Have any thoughts about
Clinuvel Pharmaceuticals Ltd?
Write Note

Wall Street
Price Targets

CUV Price Targets Summary
Clinuvel Pharmaceuticals Ltd

Wall Street analysts forecast CUV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CUV is 26.93 AUD with a low forecast of 17.17 AUD and a high forecast of 41.58 AUD.

Lowest
Price Target
17.17 AUD
32% Upside
Average
Price Target
26.93 AUD
107% Upside
Highest
Price Target
41.58 AUD
219% Upside
Clinuvel Pharmaceuticals Ltd Competitors:
Price Targets
603087
Gan & Lee Pharmaceuticals
55% Upside
301047
Sino Biological Inc
59% Upside
CDMO
Avid Bioservices Inc
6% Upside
1167
Jacobio Pharmaceuticals Group Co Ltd
145% Upside
CDNA
CareDx Inc
52% Upside
ALEC
Alector Inc
246% Upside
CCCC
C4 Therapeutics Inc
311% Upside
688739
Liaoning Chengda Biotechnology Co Ltd
53% Upside

Revenue
Forecast

Revenue Estimate
Clinuvel Pharmaceuticals Ltd

For the last 8 years the compound annual growth rate for Clinuvel Pharmaceuticals Ltd's revenue is 39%. The projected CAGR for the next 3 years is 12%.

39%
Past Growth
12%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Clinuvel Pharmaceuticals Ltd

The compound annual growth rate of Clinuvel Pharmaceuticals Ltd's operating income for the next 3 years is 8%.

N/A
Past Growth
8%
Estimated Growth
Estimates Accuracy
25%
Average Beat

Net Income
Forecast

Net Income Estimate
Clinuvel Pharmaceuticals Ltd

The compound annual growth rate of Clinuvel Pharmaceuticals Ltd's net income for the next 3 years is 13%.

N/A
Past Growth
13%
Estimated Growth
Estimates Accuracy
3%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CUV's stock price target?
Price Target
26.93 AUD

According to Wall Street analysts, the average 1-year price target for CUV is 26.93 AUD with a low forecast of 17.17 AUD and a high forecast of 41.58 AUD.

What is Clinuvel Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Clinuvel Pharmaceuticals Ltd's revenue is 39%. The projected CAGR for the next 3 years is 12%.

What is Clinuvel Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
8%

The compound annual growth rate of Clinuvel Pharmaceuticals Ltd's operating income for the next 3 years is 8%.

What is Clinuvel Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
13%

The compound annual growth rate of Clinuvel Pharmaceuticals Ltd's net income for the next 3 years is 13%.

Back to Top